AGENT FOR OSTEOMETABOLIC DISEASE

PROBLEM TO BE SOLVED: To provide a compound enabling osteometabolic diseases including osteoporosis to be prevented or treated by maximally stopping the perishment of osteoblast by hydrogen peroxide to maintain the absolute number of the osteoblast at high levels to yield osteoplastic predominance....

Full description

Saved in:
Bibliographic Details
Main Authors SHIBATA HITOSHI, HII EIICHI, YONEDA YUKIO, MORIGUCHI NOBUAKI
Format Patent
LanguageEnglish
Published 19.05.2005
Edition7
Subjects
FOODS OR FOODSTUFFS
FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT
THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide a compound enabling osteometabolic diseases including osteoporosis to be prevented or treated by maximally stopping the perishment of osteoblast by hydrogen peroxide to maintain the absolute number of the osteoblast at high levels to yield osteoplastic predominance. SOLUTION: The agent for osteometabolic diseases comprises a compound of the general formula(I)( wherein, R1and R2are each a 1-5C straight-chain or side-chain alkyl ) or a salt thereof. COPYRIGHT: (C)2005,JPO&NCIPI
Bibliography:Application Number: JP20030363891